Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials
{{output}}
Background: Fluoxetine remains the only pharmacological treatment approved for Bulimia Nervosa, and no other drugs have been approved for eating disorders (EDs). The rationale for exploring psilocybin as a treatment for EDs is co... ...
